Hemochromatosis.
The recent cloning of the hemochromatosis gene (HFE) and the demonstration that a single missense mutation is responsible for 90% or more of patients with the disease, have stimulated renewed interest in all aspects of this common disease. The molecular tests for identifying mutations in HFE provide improved means for diagnosis, family screening, and population screening. Moreover, the elucidation of the role of the HFE gene product will provide new insights into the regulation of normal iron absorption and iron metabolism. In addition, it is now apparent that iron, even in the modest tissue concentrations, can act as a co-factor in potentiating cell injury in other liver diseases.
Department of Medicine, University of Queensland, Brisbane, Australia. lawrieP@qimr.edu.au
L W
LW
Powell
T R
TR
Yapp
D003131:Combined Modality Therapy; D005260:Female; D006432:Hemochromatosis / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D008297:Male; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate